Vialwirebiotech, curated
November 21, 2026, 9:08 AM
October 9, 2026
- 11:41 AM · STAT News
- 11:18 AM · BioPharma Dive11:18 AMFDA review docs spark Revolution sell-off; Zealand diabetes data underwhelm analysts — BioPharma Dive
- 9:00 AM · BioWorld9:00 AMMarvel reports Phelan-McDermid study results with MB-204 — BioWorld
- 9:00 AM · BioWorld9:00 AMVinci raises funds to advance ocular delivery platform — BioWorld
- 9:00 AM · BioWorld
- 9:00 AM · BioWorld9:00 AMNingbo Jiefu Biotechnology discloses new compounds targeting EGFR — BioWorld
- 9:00 AM · BioWorld9:00 AMGlaukos licenses rights to Revopsis’ RO-104 for retinal diseases — BioWorld
- 9:00 AM · BioWorld9:00 AMEditas Medicine’s EDIT-401 cleared for clinic in Australia — BioWorld
- 9:00 AM · BioWorld9:00 AMAYA-1809002 shows selective, reversible anticoagulation — BioWorld
- 9:00 AM · BioWorld9:00 AMMTRX-31 targets mitochondria to drive fat loss — BioWorld
- 6:59 AM · BioPharma Dive6:59 AMTRex Bio prices $117M IPO to support immune drug work — BioPharma Dive
- 6:37 AM · Pharmaceutical Technology6:37 AMRoche’s Tecentriq snags FDA label expansion in type of colon cancer — Pharmaceutical Technology
- 6:02 AM · Pharmaceutical Technology6:02 AMBio-Techne opens GMP small molecule facility in Bristol, UK — Pharmaceutical Technology
- 6:00 AM · Drug Discovery World6:00 AMLilly and Gate agree $870m deal for molecular gate medicines — Drug Discovery World
- 5:00 AM · Drug Discovery World5:00 AMCancer vaccine extends survival in glioblastoma trial — Drug Discovery World
October 8, 2026
- 4:57 PM · BioPharma Dive4:57 PMHHS launches new plan to strengthen vaccine injury research, reporting — BioPharma Dive
- 4:30 PM · Nikkei Asia4:30 PMJapan's Terumo takes $610m hit after losing US customer for plasma device — Nikkei Asia
- 12:00 PM · BioWorld
- 12:00 PM · BioPharma Dive12:00 PMViatris boosts pain drug portfolio with $1.7B buyout of Pacira — BioPharma Dive